Dermapharm Holding SE

XTRA:DMP Stock Report

Market Cap: €2.3b

Dermapharm Holding Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

XTRA:DMP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 May 26Buy€17,795,400Themis Beteiligungs-AGCompany380,000€46.83
30 Oct 25Buy€36,250,200Themis Beteiligungs-AGCompany1,080,000€33.56

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of DMP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders260,0000.483%
Institutions4,592,2768.53%
General Public6,186,72411.5%
Private Companies42,801,00079.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 88.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
79.5%
Themis Beteiligungs-AG
42,801,000€1.8b0.9%no data
2.97%
Mawer Investment Management Ltd.
1,599,728€68.7m0%0.24%
0.82%
Vanguard Capital Management, LLC
443,140€19.0m0.11%no data
0.66%
Grandeur Peak Global Advisors, LLC
355,059€15.3m-24.3%0.69%
0.55%
Norges Bank Investment Management
297,337€12.8m0%no data
0.48%
Wilhelm Beier
260,000€11.2m0%no data
0.47%
Aberdeen Group Plc
255,418€11.0m0%0.01%
0.46%
Janus Henderson Group Ltd.
248,691€10.7m0%no data
0.43%
BlackRock, Inc.
232,356€10.0m-5.41%no data
0.26%
Deutsche Asset & Wealth Management
140,906€6.1m0%no data
0.23%
Vanguard Fiduciary Trust Company
126,315€5.4m2.19%no data
0.22%
Dimensional Fund Advisors LP
120,607€5.2m-48.1%no data
0.21%
Amundi Asset Management SAS
113,277€4.9m-3.48%no data
0.17%
KBC Asset Management NV
89,129€3.8m0%0.01%
0.16%
Candriam, Société En Commandite Par Actions
88,810€3.8m0%0.01%
0.12%
BNY Asset Management
65,882€2.8m0.41%no data
0.12%
Paladin Asset Management GmbH
64,500€2.8m0%3.92%
0.094%
UBS Asset Management AG
50,439€2.2m-5.7%no data
0.066%
Kb - Vermögensverwaltung GmbH
35,479€1.5m0%2.6%
0.059%
WisdomTree Asset Management, Inc.
31,838€1.4m-1.22%0.01%
0.054%
Charles Schwab Investment Management, Inc.
29,183€1.3m-2.8%no data
0.035%
Joh. Berenberg, Gossler & Co. KG
19,000€816.5k0%0.04%
0.035%
Knoesel & Ronge Vermögensverwaltung GmbH & Co. Kg
19,000€816.5k0%1.53%
0.033%
NFS Capital AG
18,000€773.4k0%0.4%
0.033%
Reuss Private Bank FÜR Wertpapierhandel AG
17,936€770.6k0%2.79%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 23:49
End of Day Share Price 2026/07/08 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dermapharm Holding SE is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard OrgonasBerenberg
Fabian PiastaJefferies LLC
Martin ComtesseJefferies LLC